PTSM: Pharmaceutical Technology Sourcing and Management, Jan 6, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Jan 6, 2010
Global Feature
A Pharmaceutical Ingredients Outlook
By Patricia Van Arnum
Despite a challenging current economic environment, the five-year outlook for pharmaceutical outsourcing and ingredients supply is fairly healthy.
Biotech
Financing Outlook for the US Biotechnology Industry
By Patricia Van Arnum
Buoyed by an uptick in financing from partnering deals, the US biotechnology industry reached a record high in private and public financing in 2009, but caution remains for 2010.
Outsourcing
Squeezed for Cash
By Jim Miller
Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here